局部晚期/转移性尿路细胞癌的治疗线:新的范式
Oluseyi Abidoye1, Prateek Jain1, Parminder Singh1
1Division of Hematology and Oncology, Mayo Clinic Arizona, Phoenix, AZ.
JCO oncology practice
|April 4, 2025
概括
转移性尿路细胞癌 (mUC) 治疗正在超越传统化疗. 新型疗法,如恩福图马布 (enfortumab vedotin) 加上潘布罗利祖马布 ( pembrolizumab),为患者提供了新的希望,尤其是患有并发症的老年人.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 尿路癌 (UC) 是最常见的尿路恶性瘤,膀癌占病例的90%.
- 转移性UC (mUC) 存在重大挑战,特别是在患有并发症的老年患者中.
- 基于西斯普拉丁的化疗是局部晚期mUC的长期一线治疗方法,由于患者的适用性和低于最佳生存率,它存在局限性.
研究的目的:
- 审查最近关于管理局部晚期和转移性尿路细胞癌 (LA/mUC) 的临床数据.
- 探索新疗法对LA/mUC治疗环境的影响.
- 为LA/mUC患者护理提供最佳测序策略的见解.
主要方法:
- 审查当前的临床数据和LA/mUC管理方面的进展.
- 对新型治疗药物的分析,包括抗体-药物合物和免疫疗法.
- 探索组合疗法及其临床结果.
主要成果:
- 最近的进展正在重塑LA/mUC的治疗模式.
- 组合疗法,如恩福图马布维多丁和潘布罗利祖马布,显示出有前途的临床结果.
- 多种新的药物和组合提供了增强的患者护理机会.
结论:
- 治疗LA/mUC的治疗场景正在迅速发展,新的药物和组合出现.
- 医生必须适应新的治疗选择和测序策略.
- 新兴疗法为患有晚期泌尿腺癌的患者提供了改进的治疗选择.
相关概念视频
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Urinary Tract Calculi V: Nursing Management
493
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
493
Urinary Tract Calculi VI: Surgical Management
1.0K
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
1.0K


